Inventiva (IVA) Other Working Capital Changes (2019 - 2025)
Inventiva's (IVA) quarterly Other Working Capital Changes came in at -$1.5 million in Q2 2025, down 18.02% year-on-year from -$1.8 million in Q2 2024, and down 5.93% quarter-over-quarter from -$1.4 million in Q4 2024.
Inventiva (IVA) Other Working Capital Changes (2019 - 2025) Analysis & Trends
Inventiva's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$1.5 million for Q2 2025.
- On a quarterly basis, Other Working Capital Changes fell 18.02% year-over-year to -$1.5 million in Q2 2025; TTM through Jun 2025 was -$3.2 million, a 85.89% decrease from a year earlier, with the FY2024 full-year figure at -$1.4 million, up 18.86% from the prior year.
- Other Working Capital Changes fell to -$1.5 million in Q2 2025 per IVA's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.1 million in Q1 2021 and bottomed at -$2.6 million in Q2 2024.
- The 4-year median for Other Working Capital Changes is $165590.9 (2020), against an average of -$252071.4.
- Across the five-year window, Other Working Capital Changes soared 73.35% in 2021 and slumped 3877.64% in 2022, its largest moves.
- Year by year, Other Working Capital Changes stood at -$5719.9 in 2021, then slumped by 3877.64% to -$227515.2 in 2022, then plunged by 662.33% to -$1.7 million in 2023, then advanced by 18.86% to -$1.4 million in 2024, then declined by 5.93% to -$1.5 million in 2025.
- Per Business Quant, the three latest IVA Other Working Capital Changes figures stand at -$1.5 million (Q2 2025), -$1.4 million (Q4 2024), and -$1.3 million (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -1.49 Mn |
| Jun 30, 2025 | -1.49 Mn |
| Jun 30, 2025 | -1.49 Mn |
| Dec 31, 2024 | -1.41 Mn |
| Dec 31, 2024 | -1.41 Mn |
| Dec 31, 2024 | -1.41 Mn |
| Jun 30, 2024 | -1.26 Mn |
| Jun 30, 2024 | -1.26 Mn |
| Jun 30, 2024 | -1.26 Mn |
| Dec 31, 2023 | -1.73 Mn |
| Dec 31, 2023 | -1.73 Mn |
| Dec 31, 2023 | -1.73 Mn |
| Jun 30, 2023 | -769,869.55 |
| Jun 30, 2023 | -769,869.55 |
| Jun 30, 2023 | -769,869.55 |
| Dec 31, 2022 | -227,515.16 |
| Dec 31, 2022 | -227,515.16 |
| Dec 31, 2022 | -227,515.16 |
| Sep 22, 2022 | -232,687.03 |
| Sep 22, 2022 | -232,687.03 |